We are living through the fastest period of digital growth in human history. New technologies are transforming how we live, work, connect and innovate.
The pharmaceutical industry, with its stringent regulations, demands that healthcare professionals (HCPs) often have to navigate complex onboarding processes to access digital platforms.
Anthropy23 returned to The Eden Project in Cornwall for its second year in November, once more bringing together cross-industry companies and individuals united in a shared goal: to seek su
Digital health is unlocking new avenues for innovation across life sciences, and industry leaders are keen to tap into the potential of this burgeoning area.
Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease congenital hyperinsulinism (CHI) to the US market.